Friday 23 February 2018

Kidney cancer wonder drug launched in UK

A pill for advanced kidney cancer described as "an important step" for future treatment has been launched in the UK.

Axitinib, marketed as Inlyta, is one of a new generation of drugs that cut off the blood supply to tumours.

In a late-stage phase-three trial, axitinib lengthened the time tumours stopped growing by 45pc compared with a standard treatment.

All 723 patients with advanced renal cell carcinoma had stopped responding to previous treatments. Dr Tom Powles, consultant oncologist at Barts Health NHS Trust in London, said: "Today's news marks an important step for the future treatment of patients with this cancer.

"The data supporting the treatment of patients with axitinib after progression. . . is very encouraging."

But at an estimated cost of £3,000 (€3,725) per month, it remains to be seen whether axitinib is made widely available on the NHS in the UK.

Irish Independent

Promoted Links

Today's news headlines, directly to your inbox every morning.

Promoted Links

Editors Choice

Also in World News